In this MEDtalk, Lina Moschoula Passali focuses on blood-brain barrier permeability in patients with optic neuritis, a common early symptom of multiple sclerosis (MS). The study, presented at ECTRIMS 2024, showed that blood-brain barrier permeability in the normally occurring white matter is increased in patients who already meet MS diagnostic criteria, but not before. This increase in permeability of the blood-brain barrier appears to be related to the spread of lesions across the brain. 🔗See more from ECTRIMS 2024: https://lnkd.in/d_RBxWvR #MS #Research #ECTRIMS24
Neurologi DK
Bog- og tidsskriftsforlag
Virum, Hovedstaden 203 følgere
Få seneste forskningsnyt inden for neurologi
Om os
Gå ikke glip af det nyeste fra neurologi. Læs nye artikler skrevet af specialister, se MEDtalks hvor der bl.a. præsenteres den nyeste forskning, tag faglige test og læs magasiner inden for dit fagområde.
- Websted
-
https://bpno.dk/specialer/neurologi/
Eksternt link til Neurologi DK
- Branche
- Bog- og tidsskriftsforlag
- Virksomhedsstørrelse
- 11-50 medarbejdere
- Hovedkvarter
- Virum, Hovedstaden
- Grundlagt
- 2019
Opdateringer
-
Mikkel Anthonisen, MD, specialist in MS and founder of the sailing project Oceans of Hope for patients with MS presented the first results from the project at this year’s ECTRIMS. They show that the sailing activities reduce the patients’ anxiety and depression. Furthermore, their sense of self-efficacy is lifted, and they achieve a higher quality of life. 🔗 Read more about ECTRIMS 2024: https://lnkd.in/d_RBxWvR #ECTRIMS24 #MultipleSclerosis #Sailing
Oceans of Hope Project Gives Patients with MS Higher Quality of Life
https://bpno.dk
-
Exercise, once discouraged for MS patients, is now considered crucial in treatment. This study, presented by Professor Ulrik Dalgas, discusses the benefits of exercise for individuals with multiple sclerosis (MS), focusing on cognitive and physical functions. Early intervention and the right exercise type and dosage are essential for maximizing these benefits. 🔗 Read more about ECTRIMS 2024 here: https://lnkd.in/d_RBxWvR #ECTRIMS24 #MultipleSclerosis #Treatment
Exercise is Essential for Maximizing Cognitive and Physical Functions for Individuals with MS
https://bpno.dk
-
Denne undersøgelse undersøgte effekten af et fire-ugers tværfagligt rehabiliteringsprogram af fatigue hos personer med MS. Patienter, der deltog i programmet, rapporterede om reduceret fatigue 6 og 12 måneder efter rehabiliteringen. De, der modtog mere målrettede interventioner mod fatigue, oplevede endnu større forbedringer. Resultaterne tyder på, at programmet positivt påvirker dagligdagen og livskvaliteten. Hør Lars Hvid fra de danske MS-hospitaler uddybe dette ved ECTRIMS 2024. 🔗 Følg med på ECTRIMS-siden: https://lnkd.in/d_RBxWvR #ECTRIMS24 #MS
Tværfaglig rehabilitering giver positive langtidseffekter mod fatigue hos personer med MS
https://bpno.dk
-
This study, presented at ECTRIMS 2024 by Marie Lynning, investigated health literacy in people with MS, focusing on two domains: understanding health information and engaging with healthcare providers. Results showed that individuals with MS face more challenges compared to the general population. Especially low health literacy was linked to lower education levels, progressive disease types, and higher disease severity. 🔗 Read more about ECTRIMS 2024 here: https://lnkd.in/d_RBxWvR #ECTRIMS24 #MultipleSclerosis
Low Health Literacy is Associated with Lower Levels of Education, Progressive Disease Types and Higher Disease Severity in MS
https://bpno.dk
-
A study presented at ECTRIMS 2024 has identified key biomarkers that can accurately predict disability progression in multiple sclerosis (MS). These findings have the potential to significantly impact MS treatment approaches, enabling the development of more personalized and effective therapeutic strategies tailored to individual patient profiles. 🔗Follow along as we cover the 2024 ECTRIMS Congress: https://lnkd.in/d_RBxWvR #ECTRIMS24 #MS
ECTRIMS 2024: New Data Has the Potential to Paving the Way for More Personalised and Effective Treatment Plans
https://bpno.dk
-
At ECTRIMS 2024, Melinda Magyari presented a study that analyzed mortality trends in multiple sclerosis (MS) patients in Denmark using Danish Multiple Sclerosis Registry data. It showed that patients with secondary progressive MS had a significantly higher mortality risk and lived about ten years shorter than primary progressive MS patients, emphasizing the need to focus on managing this stage of MS. 🔗 Read more about ECTRIMS 2024: https://lnkd.in/d_RBxWvR #ECTRIMS24 #MultipleSclerosis
Patients with Secondary Progressive MS Have a Higher Mortality than Those with Primary Progressive MS
https://bpno.dk
-
New research presented at ECTRIMS 2024 reveals that initiating monoclonal antibody therapy during childhood significantly reduces long-term disability in multiple sclerosis patients. 🔗 Read more about ECTRIMS 2024 here: https://lnkd.in/d_RBxWvR #ECTRIMS24 #MultipleSclerosis
Earlier Access to Effective Treatments for Children with MS Reduces the Burden of Long-Term Disability - BestPractice Nordic
https://bpno.dk
-
From September 18-20, 2024, the 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) will take place at Bella Center Copenhagen. BestPractice Nordic will be on-site to cover the event, providing updates on the latest breakthroughs in multiple sclerosis (MS) research and treatment. 🔗Follow along for the highlights: https://lnkd.in/d_RBxWvR #ECTRIMS24
ECTRIMS 2024: The World’s Largest MS Congress in Copenhagen - BestPractice Nordic
https://bpno.dk
-
In this MEDtalk, Nils Erik Gilhus, professor of neurology, discusses new ongoing treatments for myasthenia gravis. They have been shown to be effective and appear to have few side effects. He also presents the Nordic guidance and some interesting studies from the Nordic countries. 🔗 See more from the European Academy of Neurology 2024 Congress: https://lnkd.in/dV62Xfaq #EAN24 #Myastheniagravis
EAN 2024: Highlights Regarding Myasthenia Gravis
https://bpno.dk